Why the study?
Data on the role of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in managing fulminant myocarditis are limited.
Does veno-arterial extracorporeal membrane oxygenation (VA-ECMO) improve outcomes in patients with fulminant myocarditis?
Does veno-arterial extracorporeal membrane oxygenation (VA-ECMO) improve outcomes in patients with fulminant myocarditis?
This review summarizes contemporary literature on the management of fulminant myocarditis, focusing on the role and outcomes of VA-ECMO.
Limited data guide VA-ECMO use in fulminant myocarditis; leaves open optimal selection, timing, and outcomes.
Fulminant myocarditis is characterized by life threatening heart failure presenting as cardiogenic shock requiring inotropic or mechanical circulatory support to maintain tissue perfusion. There are limited data on the role of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in the management of fulminant myocarditis. This review seeks to evaluate the management of fulminant myocarditis with a special emphasis on the role and outcomes with VA-ECMO use.
No takes yet. Share an insight, caveat, or question.
Venkataraman et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: